Filing Details
- Accession Number:
- 0001209191-19-003464
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-11 18:15:19
- Reporting Period:
- 2019-01-11
- Accepted Time:
- 2019-01-11 18:15:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879407 | Arrowhead Pharmaceuticals Inc. | ARWR | Pharmaceutical Preparations (2834) | 460408024 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1553338 | D. William Waddill | 225 S. Lake Avenue Suite 1050 Pasadena CA 91101 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-01-11 | 8,500 | $14.77 | 46,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units.
Billionaire Hedge Funds
